Get the latest Acutaas Chemicals share price today on NSE & BSE. Explore Acutaas Chemicals stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

Sandoz announced the launch of generic rivaroxaban in Germany in August 2025, introducing new generic strengths of 10 mg, 15 mg, and 20 mg after the dosage patent was revoked, following their legal ...

In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared with ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar ...

Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke. (HealthDay News) — Subcutaneous injection of abelacimab results ...

Rivaroxaban, a direct oral anticoagulant (DOAC), demonstrated greater efficacy and similar safety compared with warfarin in patients with chronic kidney disease and atrial fibrillation. Rivaroxaban, a ...

Blood clot Researchers sought to compare apixaban and rivaroxaban for patients with gastrointestinal cancer in terms of risk of recurrent of VTE or bleeding. Either of the direct oral anticoagulants ...

At both 6 months and 12 months follow-up, the rivaroxaban group was found to have more of these events than the apixaban group. Credit: Getty Images. In patients with atrial fibrillation and valvular ...

BOSTON, MA—For patients undergoing transradial coronary procedures, a short course of rivaroxaban (Xarelto; Bayer/Janssen) reduces the rate of radial artery occlusion without significantly increasing ...

Contrary to expectations, vitamin K antagonists (VKAs) reduced the risk for ischemic stroke and death compared with the factor Xa inhibitor rivaroxaban (Xarelto, Janssen) in patients with rheumatic ...

Please provide your email address to receive an email when new articles are posted on . For the two-part UNIVERSE study, 12 children who underwent the Fontan procedure were enrolled in a single-arm ...